zagociguat 15 mg clinical trials

An open-label extension study evaluating the safety of zagociguat in participants with MELAS who completed TIS6463-203

This study is looking into the long-term safety of a new medicine called zagociguat for people with MELAS, a rare genetic condition. It's for those who have already been in an earlier study of the drug. Researchers will check for any side effects.